Tong A C, Rattigan S, Dora K A, Clark M G
Division of Biochemistry, University of Tasmania, Hobart, Australia.
Can J Physiol Pharmacol. 1997 Jul;75(7):763-71.
Norepinephrine and angiotensin II are potent vasoconstrictors and stimulate thermogenesis (oxygen uptake) as well as lactate and glycerol efflux in the constant-flow perfused rat hind limb at rest. However, the mechanism by which oxygen uptake (VO2) is increased is unknown, and it is not clear whether vasoconstriction is required for the increase in VO2 by the hind limb. In the present study the association between vasoconstriction and VO2 was further investigated, and a chance observation that high-dose propranolol selectively blocked vasoconstrictor-induced increase in VO2 was further explored. The norepinephrine-mediated increase in VO2 was totally blocked by either 50 microM (+)-propranolol or 50 microM (-)-propranolol (active beta-blocking enantiomer), but only (+)-propranolol reduced the vasoconstriction. Similarly, 100 microM (+/-)-propranolol (a dose likely to cause plasma membrane stabilizing effects involving interruption and (or) prevention of action potentials) blocked increases in VO2, lactate, and glycerol efflux by 5 nM angiotensin II (a nonadrenergic vasoconstrictor) with only marginal effects on pressure development. (+/-)-Propranolol (100 microM) had no effect on postequilibration red blood cell washout mediated by angiotensin II, a putative indicator of vasoconstrictor-induced redistribution of flow. Quinidine (260 microM) (an antiarrhythmic agent with membrane-stabilizing activity) inhibited only the increase in VO2, but neither nadolol (300 microM) nor atenolol (300 microM) (beta-blockers without membrane-stabilizing activity) inhibited VO2 or perfusion pressure increases produced by 5 nM angiotensin II. Veratridine (a membrane labilizer that is capable of evoking plasma membrane depolarization by maintaining voltage-gated Na+ channels in their open state) increased VO2 without vasoconstriction, and the increase in VO2 was blocked by 100 microM (+/-)-propranolol. It is concluded that the increase in hind-limb VO2 results from a destabilization of skeletal muscle plasma membranes. This can be achieved directly by veratridine or indirectly by angiotensin II, involving vasoconstriction and redistribution of flow. The findings suggest a novel mechanism for resting muscle thermogenesis.
去甲肾上腺素和血管紧张素II是强效血管收缩剂,在静息状态下,能刺激恒流灌注的大鼠后肢的产热(摄氧量)以及乳酸和甘油外流。然而,摄氧量(VO2)增加的机制尚不清楚,后肢VO2增加是否需要血管收缩也不明确。在本研究中,进一步探讨了血管收缩与VO2之间的关联,并对高剂量普萘洛尔选择性阻断血管收缩剂诱导的VO2增加这一偶然观察结果进行了深入研究。去甲肾上腺素介导的VO2增加被50微摩尔(+)-普萘洛尔或50微摩尔(-)-普萘洛尔(活性β-阻断对映体)完全阻断,但只有(+)-普萘洛尔能减轻血管收缩。同样,100微摩尔(±)-普萘洛尔(该剂量可能会引起涉及中断和(或)预防动作电位的质膜稳定作用)可阻断5纳摩尔血管紧张素II(一种非肾上腺素能血管收缩剂)引起的VO2、乳酸和甘油外流增加,对压力升高仅有轻微影响。(±)-普萘洛尔(100微摩尔)对血管紧张素II介导的平衡后红细胞清除率没有影响,红细胞清除率被认为是血管收缩剂诱导的血流重新分布的一个指标。奎尼丁(260微摩尔)(一种具有膜稳定活性的抗心律失常药物)仅抑制VO2的增加,但纳多洛尔(300微摩尔)和阿替洛尔(300微摩尔)(无膜稳定活性的β-阻滞剂)均未抑制5纳摩尔血管紧张素II引起的VO2或灌注压力升高。藜芦碱(一种膜不稳定剂,能够通过使电压门控钠通道保持开放状态来引起质膜去极化)在不引起血管收缩的情况下增加VO2,且100微摩尔(±)-普萘洛尔可阻断VO2的增加。得出的结论是,后肢VO2的增加是由骨骼肌质膜不稳定导致的。这可以通过藜芦碱直接实现或通过血管紧张素II间接实现,后者涉及血管收缩和血流重新分布。这些发现提示了静息肌肉产热的一种新机制。